Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.23.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 3,800 $ 3,173
Restricted cash 6,300
Accounts receivable, net 8,582 6,744
Inventories, net 7,541 10,257
Prepaid expenses and other current assets 992 1,051
Total Current Assets 20,915 27,525
Fixed assets, net 258 375
Right-of-use assets, operating leases 134 173
Intangible assets, net 8,914 10,059
Other assets 828 544
Total Assets 31,049 38,676
Current Liabilities    
Accounts payable 7,807 2,932
Accrued and other liabilities 2,525 2,596
Line of credit, net 1,917
Warrants liabilities 869
Operating lease liability 56 52
Total Current Liabilities 13,174 5,580
Non-current Liabilities    
Line of credit, net 11,444
Term loan, net 2,714
Operating lease liability 82 124
Total Non-current Liabilities 2,796 11,568
Total Liabilities 15,970 17,148
Stockholders’ Equity    
Common Stock, $0.001 par value, 200,000,000 shares authorized, 32,077,148 & 29,430,267 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 32 29
Additional paid-in capital 321,688 320,071
Accumulated deficit (306,641) (298,572)
Total Stockholders’ Equity 15,079 21,528
Total Liabilities and Stockholders’ Equity $ 31,049 $ 38,676